Skip to main content
Journal cover image

Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients.

Publication ,  Journal Article
Osazuwa-Peters, OL; Greiner, MA; Oberle, A; Oakes, M; Thomas, SM; Bosworth, H
Published in: J Allergy Clin Immunol Pract
September 2022

BACKGROUND: Adherence barriers to asthma biologics may not be uniform across administration settings for patients with moderate-to-severe asthma. OBJECTIVE: To examine differences in asthma biologic adherence and associated factors, as well as association with a 1-year all-cause emergency department (ED) visit, across administration settings. METHODS: A retrospective study of biologic naïve moderate-to-severe asthma patients with initial biologic therapy between January 1, 2016, and April 30, 2020, in the Optum Clinformatics Data Mart was performed. Three administration settings were identified: Clinic-only (outpatient office/infusion center), Home (self-administration), and Hybrid setting (mixture of clinic and self-administration). Asthma biologic adherence was the proportion of observed over expected biologic dose administrations received within 6 months from initial therapy. Factors associated with adherence were identified by administration setting, using Poisson regression analyses. A relationship between a 1-year all-cause ED visit and adherence was assessed for each administration setting using Cox regression analyses. RESULTS: The study cohort was 3932 patients. Biologics adherence was 0.75 [0.5, 1] in Clinic setting, the most common administration setting, and 0.83 [0.5, 1] in both Home and Hybrid settings. Specialist access was consistently associated with better biologic adherence, whereas Black race, Hispanic ethnicity, lower education, Medicare only insurance, and higher patient out-of-pocket cost were associated with worse biologic adherence in some settings. In the Hybrid setting, hazard for a 1-year all-cause ED visit decreased with biologic adherence. CONCLUSIONS: Asthma biologic adherence varied by administration setting. Efforts to improve asthma biologic adherence should consider promoting self-administration when beneficial, improving prior specialist access, and targeting patients with higher risk of suboptimal adherence particularly Black and Hispanic patients.

Duke Scholars

Published In

J Allergy Clin Immunol Pract

DOI

EISSN

2213-2201

Publication Date

September 2022

Volume

10

Issue

9

Start / End Page

2355 / 2366

Location

United States

Related Subject Headings

  • United States
  • Retrospective Studies
  • Medication Adherence
  • Medicare
  • Humans
  • Cohort Studies
  • Biological Products
  • Asthma
  • Aged
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Osazuwa-Peters, O. L., Greiner, M. A., Oberle, A., Oakes, M., Thomas, S. M., & Bosworth, H. (2022). Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients. J Allergy Clin Immunol Pract, 10(9), 2355–2366. https://doi.org/10.1016/j.jaip.2022.05.022
Osazuwa-Peters, Oyomoare L., Melissa A. Greiner, Amber Oberle, Megan Oakes, Sheila M. Thomas, and Hayden Bosworth. “Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients.J Allergy Clin Immunol Pract 10, no. 9 (September 2022): 2355–66. https://doi.org/10.1016/j.jaip.2022.05.022.
Osazuwa-Peters OL, Greiner MA, Oberle A, Oakes M, Thomas SM, Bosworth H. Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2355–66.
Osazuwa-Peters, Oyomoare L., et al. “Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients.J Allergy Clin Immunol Pract, vol. 10, no. 9, Sept. 2022, pp. 2355–66. Pubmed, doi:10.1016/j.jaip.2022.05.022.
Osazuwa-Peters OL, Greiner MA, Oberle A, Oakes M, Thomas SM, Bosworth H. Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2355–2366.
Journal cover image

Published In

J Allergy Clin Immunol Pract

DOI

EISSN

2213-2201

Publication Date

September 2022

Volume

10

Issue

9

Start / End Page

2355 / 2366

Location

United States

Related Subject Headings

  • United States
  • Retrospective Studies
  • Medication Adherence
  • Medicare
  • Humans
  • Cohort Studies
  • Biological Products
  • Asthma
  • Aged
  • 3204 Immunology